Germany Drug Delivery Devices Market Outlook to 2023-Central Venous Catheters, Infusion Systems, Needle Free Injections and Metered Dose Inhaler Devices

Germany Drug Delivery Devices Market Outlook to 2023-Central Venous Catheters, Infusion Systems, Needle Free Injections and Metered Dose Inhaler Devices


  • Products Id :- GDMEMC0244DB
  • |
  • Pages: 162
  • |
  • |
  • |
  Request for Sample Report
  Request A Quote

Executive Summary

Germany Drug Delivery Devices Market Outlook to 2023-Central Venous Catheters, Infusion Systems, Needle Free Injections and Metered Dose Inhaler Devices

Summary

GlobalData's new report, "Germany Drug Delivery Devices Market Outlook to 2023", provides key market data on the Germany Drug Delivery Devices market. The report provides value, in millions of US dollars and volume (in units) within market categories-Central Venous Catheters, Needle Free Injections, Infusion Systems and Metered Dose Inhaler Devices.

The report also provides company shares and distribution shares data for each of these market categories, and global corporate-level profiles of the key market participants. Based on the availability of data for the particular market and country, information related to pipeline products, news and deals is available in the report.

Extensive interviews are conducted with key opinion leaders (KOLs), physicians and industry experts to validate the market size, company share and distribution share data and analysis.

Scope

Market size and company share data for Drug Delivery Devices market categories-Central Venous Catheters, Needle Free Injections, Infusion Systems and Metered Dose Inhaler Devices.

Annualized market revenues (USD million) and volume (units) data for each of the market categories. Data is provided from 2009 to 2016 and forecast to 2023.

2016 company shares and distribution shares data for each of the market categories.

Global corporate-level profiles of key companies operating within the Germany Drug Delivery Devices market.

Key players covered include GlaxoSmithKline Plc, AstraZeneca Plc, Hospira Inc, Becton Dickinson and Co, Boehringer Ingelheim GmbH, Baxter International Inc, Medtronic plc and others.

Reasons to buy

Develop business strategies by identifying the key market categories poised for strong growth in the future.

Develop market-entry and market expansion strategies.

Design competition strategies by identifying who-stands-where in the market.

Develop investment strategies by identifying the key market categories expected to register strong growth in the near future.

What are the key distribution channels and what's the most preferred mode of product distribution-Identify, understand and capitalize.



Read More



Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications

+91-9015378249

1 Table of Contents

1 Table of Contents 2

1.1 List of Tables 6

1.2 List of Figures 8

2 Introduction 9

2.1 What Is This Report About? 9

2.2 Drug Delivery Devices Market Segmentation 9

2.3 Definitions of Markets Covered in the Report 10

3 Drug Delivery Devices Market, Germany 13

3.1 Drug Delivery Devices Market, Germany, Revenue ($m), 2009-2023 13

3.2 Drug Delivery Devices Market, Germany, Revenue Mix ($m), 2016 15

3.3 Drug Delivery Devices Market, Germany, Category Contribution by Revenue ($m), 2016 16

3.4 Drug Delivery Devices Market, Germany, Category Comparison by Revenue ($m), 2009-2023 17

3.5 Drug Delivery Devices Market, Germany, Revenue ($m), 2009-2016 18

3.6 Drug Delivery Devices Market, Germany, Revenue ($m), 2016-2023 20

3.7 Drug Delivery Devices Market, Germany, Volume (Units), 2009-2023 22

3.8 Drug Delivery Devices Market, Germany, Volume (Units), 2009-2016 24

3.9 Drug Delivery Devices Market, Germany, Volume (Units), 2016-2023 26

3.10 Drug Delivery Devices Market, Germany, Company Share by Revenue ($m), 2016 28

4 Central Venous Catheters Market, Germany 30

4.1 Central Venous Catheters Market, Germany, Revenue Mix ($m), 2016 30

4.2 Central Venous Catheters Market, Germany, Segment Contribution (%), 2016 31

4.1 Central Venous Catheters Market, Germany, Revenue ($m), 2009-2016 32

4.2 Central Venous Catheters Market, Germany, Revenue ($m), 2016-2023 34

4.3 Central Venous Catheters Market, Germany, Volume (Units), 2009-2016 36

4.4 Central Venous Catheters Market, Germany, Volume (Units), 2016-2023 38

4.6 Central Venous Catheters Market, Germany, Distribution Share by Revenue ($m), 2015-2016 40

4.7 Central Venous Catheters Market, Germany, Company Share by Revenue ($m), 2016 41

5 Infusion Systems Market, Germany 43

5.1 Infusion Systems Market, Germany, Revenue Mix ($m), 2016 43

5.2 Infusion Systems Market, Germany, Segment Contribution (%), 2016 44

5.3 Infusion Systems Market, Germany, Revenue ($m), 2009-2016 46

5.4 Infusion Systems Market, Germany, Revenue ($m), 2016-2023 48

5.4.1 Ambulatory Infusion Pumps Market, Germany, Revenue ($m), by Segment, 2009-2016 50

5.4.2 Syringe Pumps Market, Germany, Revenue ($m), by Segment, 2009-2016 52

5.4.3 Ambulatory Infusion Pumps Market, Germany, Revenue ($m), by Segment, 2016-2023 54

5.4.4 Syringe Pumps Market, Germany, Revenue ($m), by Segment, 2016-2023 56

5.5 Infusion Systems Market, Germany, Volume (Units), 2009-2016 58

5.6 Infusion Systems Market, Germany, Volume (Units), 2016-2023 60

5.6.1 Ambulatory Infusion Pumps Market, Germany, Volume (Units), by Segment, 2009-2016 62

5.6.2 Syringe Pumps Market, Germany, Volume (Units), by Segment, 2009-2016 64

5.6.3 Ambulatory Infusion Pumps Market, Germany, Volume (Units), by Segment, 2016-2023 66

5.6.4 Syringe Pumps Market, Germany, Volume (Units), by Segment, 2016-2023 68

5.7 Infusion Systems Market, Germany, Distribution Share by Revenue ($m), 2015-2016 70

5.8 Infusion Systems Market, Germany, Company Share by Revenue ($m), 2016 71

6 Metered Dose Inhaler Devices Market, Germany 73

6.1 Metered Dose Inhaler Devices Market, Germany, Revenue ($m), 2009-2016 73

6.2 Metered Dose Inhaler Devices Market, Germany, Revenue ($m), 2016-2023 74

6.3 Metered Dose Inhaler Devices Market, Germany, Volume (Units), 2009-2016 75

6.4 Metered Dose Inhaler Devices Market, Germany, Volume (Units), 2016-2023 76

6.5 Metered Dose Inhaler Devices Market, Germany, Distribution Share by Revenue ($m), 2015-2016 77

6.6 Metered Dose Inhaler Devices Market, Germany, Company Share by Revenue ($m), 2016 78

7 Needle Free Injections Market, Germany 80

7.1 Needle Free Injections Market, Germany, Revenue ($m), 2009-2016 80

7.2 Needle Free Injections Market, Germany, Revenue ($m), 2016-2023 81

7.3 Needle Free Injections Market, Germany, Volume (Units), 2009-2016 82

7.4 Needle Free Injections Market, Germany, Volume (Units), 2016-2023 83

7.5 Needle Free Injections Market, Germany, Distribution Share by Revenue ($m), 2015-2016 84

7.6 Needle Free Injections Market, Germany, Company Share by Revenue ($m), 2016 85

8 Overview of Key Companies in Germany, Drug Delivery Devices Market 87

8.1 B. Braun Melsungen AG 87

8.1.1 Company Overview 87

8.2 Teleflex Inc 87

8.2.1 Company Overview 87

8.3 GlaxoSmithKline Plc 87

8.3.1 Company Overview 87

8.4 C. R. Bard Inc 87

8.4.1 Company Overview 87

8.5 Edwards Lifesciences Corp 88

8.5.1 Company Overview 88

8.6 AstraZeneca Plc 88

8.6.1 Company Overview 88

8.7 Boehringer Ingelheim GmbH 88

8.7.1 Company Overview 88

8.8 Pfizer Inc 88

8.8.1 Company Overview 88

8.9 Baxter International Inc 89

8.9.1 Company Overview 89

8.10 Merck & Co Inc 89

8.10.1 Company Overview 89

8.11 Becton Dickinson and Co 89

8.11.1 Company Overview 89

8.12 Fresenius Kabi AG 90

8.12.1 Company Overview 90

8.13 Smiths Medical 90

8.13.1 Company Overview 90

8.14 Medtronic Plc 90

8.14.1 Company Overview 90

8.15 Nipro Corp 91

8.15.1 Company Overview 91

8.16 Hospira Inc 91

8.16.1 Company Overview 91

8.17 Terumo Corp 91

8.17.1 Company Overview 91

9 Drug Delivery Devices Market Pipeline Products 92

10 Financial Deals Landscape 98

10.1 Acquisition 98

10.1.1 Dietmar Hopp May Sell its Stake in LTS Lohmann Therapie-Systeme 98

10.1.2 Luye Pharma Acquires Acino and Acino Supply for USD269 Million 99

10.2 Asset Transactions 101

10.2.1 ICU Medical Acquires Hospira Infusion Systems Business from Pfizer 101

10.3 Debt Offerings 103

10.3.1 Fresenius Raises USD742.5 Million in Private Placement of 0.875% Notes Due 2022 103

10.3.2 Fresenius Raises USD742.5 Million in Private Placement of 1.5% Notes Due 2024 104

10.3.3 Fresenius Raises USD742.5 Million in Private Placement of 2.125% Notes Due 2027 105

10.3.4 Fresenius Raises USD530.4 Million in Private Placement of 3% Notes Due 2032 106

10.4 Equity Offerings 107

10.4.1 Magforce Raises USD5.6 Million in Private Placement of Shares 107

10.5 Partnerships 108

10.5.1 Alimera Sciences Enters into Licensing Agreement with pSivida 108

10.5.2 Vetter Pharma International and Microdermics Enter into Agreement 109

10.5.3 Ferring International and Alrise Biosystems Enter into Co-Development Agreement 110

10.5.4 Bluegrass Vascular Enters into Partnership with Merit Medical 111

10.5.5 Aequus Pharma to Enter into Licensing Agreement with Transdermal Research Pharm Labs 112

10.5.6 Valeant Pharma Enters into Licensing Agreement with EyeGate Pharma 113

10.5.7 Propeller Health Enters into Agreement with Novartis Pharma 115

10.5.8 Neuronex Enters Into Licensing Agreement With SK Biopharmaceuticals For DZNS Technology 116

10.5.9 Pfizer Terminates its Licensing Agreement with pSivida 117

10.5.10 BioMed X Enters into Agreement with Merck 118

10.5.11 Bayer Enters into Licensing Agreement with DelSiTech 119

10.5.12 BioCorRx Enters into Licensing Agreement with Therakine 120

10.6 Venture Financing 121

10.6.1 AMW Raises USD6.4 Million in Venture Financing 121

11 Recent Developments 122

11.1 Corporate Communications 122

11.1.1 Jun 29, 2017: Bernhard Kernen named CFO of Raumedic 122

11.1.2 Jun 27, 2017: NOVALIQ Strengthens Executive Management Team with the Appointment of Gabriela Burian, MD, MPH, as Chief Medical Officer 122

11.1.3 May 12, 2017: Constantin Birnstiel to Become Head of Group Communications at Merck 123

11.1.4 Apr 12, 2017: Change in the B. Braun Management Board and the Aesculap Management Board 123

11.1.5 Apr 05, 2017: New member of the Executive Board appointed 123

11.1.6 Mar 28, 2017: Vetter�s Dr. Claudia Roth is appointed to the Fraunhofer Advisory Board 123

11.1.7 Feb 22, 2017: Change in the B. Braun Management Board 124

11.1.8 Feb 07, 2017: Haselmeier Appoints Paul Jansen as Senior Advisor and Member of the Board of Directors 124

11.1.9 Jan 13, 2017: Fresenius Medical Care Announces Leadership Change in North America 124

11.1.10 Jan 09, 2017: leon Appoints Pharma Expert Michael Mehler as Chief Executive Officer 125

11.1.11 Jan 09, 2017: leon-nanodrugs Appoints Pharma Expert Michael Mehler as Chief Executive Officer 125

11.1.12 Oct 31, 2016: TCT 2016: Orsiro Drug-Eluting Stent Proves Non-Inferiority to Resolute Integrity and Synergy Stents 126

11.1.13 Sep 23, 2016: Merck Appoints Isabel De Paoli as Chief Strategy Officer 127

11.1.14 Aug 10, 2016: MagForce announces positive results of 2016 Annual General Meeting 127

11.1.15 Jul 22, 2016: LTS Lohmann Therapie-Systeme Appoints New Chief TechOps Officer 128

11.2 Financial Announcements 128

11.2.1 Jun 30, 2017: MagForce Publishes Financial Results for the Year 2016 and Operative Highlights 128

11.2.2 May 18, 2017: Merck Continues to Grow Profitably in the First Quarter 130

11.2.3 Apr 05, 2017: Successful financial year 2016 for Boehringer Ingelheim 132

11.2.4 Mar 31, 2017: B. Braun continues its sales and earnings growth 133

11.2.5 Oct 27, 2016: Fresenius: Continued strong sales and earnings growth; Lower end of Group earnings guidance raised 134

11.2.6 Sep 30, 2016: MagForce Publishes Financial Results for the First Half of 2016 and Operative Highlights 137

11.2.7 Aug 04, 2016: Merck Lifts Forecast Following Good Second Quarter 139

11.2.8 Aug 01, 2016: Fresenius Medical Care posts accelerated earnings growth in the 2nd quarter 141

11.3 Legal And Regulatory 143

11.3.1 Jan 31, 2017: Fresenius Medical Care reaches agreement on outstanding payments 143

11.3.2 Dec 13, 2016: TUV Certification for the Bengaluru Facility 143

11.3.3 Nov 30, 2016: New Vetter data processing center is officially certified 144

11.4 Other Significant Developments 144

11.4.1 Jul 12, 2017: Merck Refines Western European Life Science Production Site Network 144

11.4.2 Jul 12, 2017: Fresenius Medical Care successfully amends and extends its credit agreement, ahead of schedule 145

11.4.3 Jun 08, 2017: B. Braun is participating in the third edition of the High-Tech Founders Fund 145

11.4.4 Apr 28, 2017: MEDITE Cancer Diagnostics Announces Reorganization of Germany Operations 145

11.4.5 Mar 21, 2017: Merck Accelerator Hits New Peak of Applications 146

11.4.6 Mar 10, 2017: Fresenius Kabi builds new warehouse at Blonie production site 146

11.4.7 Mar 09, 2017: Merck Generates Record Sales and Continues to Grow Profitably in 2016 147

11.4.8 Nov 15, 2016: Merck Raises Profit Forecast for 2016 Following Good Third Quarter 148

11.4.9 Oct 11, 2016: Fresenius Kabi Joins Chicago Health Innovation Incubator MATTER as Newest Strategic Partner 150

11.4.10 Aug 17, 2016: Fresenius Kabi investing nearly $250 million to expand plant near Chicago 150

11.4.11 Aug 03, 2016: Boehringer Ingelheim: Growth in all core businesses 150

11.4.12 Jul 19, 2016: MilliporeSigma Starts Construction on $115 Million Multi-faceted Life Science Campus in Burlington, Massachusetts 151

11.5 Product News 152

11.5.1 May 03, 2017: B. Braun Focused on Peripheral Vascular Access & Hazardous Drug Safety at INS 152

11.6 Strategy And Business Planning 153

11.6.1 Jul 06, 2017: Fresenius Kabi expands production site in Portugal 153

11.6.2 Jun 29, 2017: Merck Expands Packaging Capacity at Swiss Biotech Manufacturing Site of Aubonne 153

11.6.3 Jun 20, 2017: Merck Ventures Creates New Immuno-Oncology Company iOnctura 153

11.6.4 Jun 08, 2017: Fresenius Medical Care sees excellent prospects for further growth and launches a new Global Efficiency Program at its Capital Markets Day 2017 154

11.6.5 May 16, 2017: Merck: Optimizing the Further Development of the Darmstadt Site 154

11.6.6 Apr 20, 2017: Merck Provides Upgraded Manufacturing Capabilities to BioInvent with Single-use Mobius Bioreactors 155

11.6.7 Feb 16, 2017: GSK and EMBL have signed an agreement to enhance understanding of disease and drug mechanisms 155

11.6.8 Nov 22, 2016: HELIOS lays foundation stone for new hospital building in Wiesbaden 156

11.6.9 Oct 13, 2016: Merck Sets its Sights on 2018 and Outlines Future Strategic Roadmap 156

12 Appendix 158

12.1 Research Methodology 159

12.1.1 Coverage 159

12.1.2 Secondary Research 159

12.1.3 Primary Research 160

12.1.4 Company Share Analysis 160

12.1.5 Distribution Share Analysis 160

12.1.6 Benchmarking 161

12.2 GlobalData Consulting 161

12.3 Contact Us 162

12.4 Disclaimer 162

1.2 List of Figures

Figure 1: Drug Delivery Devices Market, Germany, Revenue ($m), USD Constant, 2009-2023 13

Figure 2: Drug Delivery Devices Market, Germany, Revenue Mix ($m), 2016 15

Figure 3: Drug Delivery Devices Market, Germany, Category Contribution (%), 2016 16

Figure 4: Drug Delivery Devices Market, Germany, Category Comparison by Revenue ($m), 2009-2023 17

Figure 5: Drug Delivery Devices Market, Germany, Revenue ($m), USD Constant, Historic, 2009-2016 18

Figure 6: Drug Delivery Devices Market, Germany, Revenue ($m), USD Constant, Forecast, 2016-2023 20

Figure 7: Drug Delivery Devices Market, Germany, Volume (Units), 2009-2023 22

Figure 8: Drug Delivery Devices Market, Germany, Volume (Units), Historic, 2009-2016 24

Figure 9: Drug Delivery Devices Market, Germany, Volume (Units), Forecast, 2016-2023 26

Figure 10: Drug Delivery Devices Market, Germany, Company Share (%) 2016 28

Figure 11: Central Venous Catheters Market, Germany, Revenue Mix ($m), 2016 30

Figure 12: Central Venous Catheters Market, Germany, Segment Contribution (%), 2016 31

Figure 13: Central Venous Catheters Market, Germany, Revenue ($m), USD Constant, Historic, 2009-2016 32

Figure 14: Central Venous Catheters Market, Germany, Revenue ($m), USD Constant, Forecast, 2016-2023 34

Figure 15: Central Venous Catheters Market, Germany, Volume (Units), Historic, 2009-2016 36

Figure 16: Central Venous Catheters Market, Germany, Volume (Units), Forecast, 2016-2023 38

Figure 17: Central Venous Catheters Market, Germany, Company Share (%) 2016 41

Figure 18: Infusion Systems Market, Germany, Revenue Mix ($m), 2016 43

Figure 19: Infusion Systems Market, Germany, Segment Contribution (%), 2016 44

Figure 20: Infusion Systems Market, Germany, Revenue ($m), USD Constant, Historic, 2009-2016 46

Figure 21: Infusion Systems Market, Germany, Revenue ($m), USD Constant, Forecast, 2016-2023 48

Figure 22: Ambulatory Infusion Pumps Market, Germany, Revenue ($m), USD Constant, Historic, 2009-2016 50

Figure 23: Syringe Pumps Market, Germany, Revenue ($m), USD Constant, Historic, 2009-2016 52

Figure 24: Ambulatory Infusion Pumps Market, Germany, Revenue ($m), USD Constant, Forecast, 2016-2023 54

Figure 25: Syringe Pumps Market, Germany, Revenue ($m), USD Constant, Forecast, 2016-2023 56

Figure 26: Infusion Systems Market, Germany, Volume (Units), Historic, 2009-2016 58

Figure 27: Infusion Systems Market, Germany, Volume (Units), Forecast, 2016-2023 60

Figure 28: Ambulatory Infusion Pumps Market, Germany, Volume (Units), Historic, 2009-2016 62

Figure 29: Syringe Pumps Market, Germany, Volume (Units), Historic, 2009-2016 64

Figure 30: Ambulatory Infusion Pumps Market, Germany, Volume (Units), Forecast, 2016-2023 66

Figure 31: Syringe Pumps Market, Germany, Volume (Units), Forecast, 2016-2023 68

Figure 32: Infusion Systems Market, Germany, Company Share (%) 2016 71

Figure 33: Metered Dose Inhaler Devices Market, Germany, Revenue ($m), USD Constant, Historic, 2009-2016 73

Figure 34: Metered Dose Inhaler Devices Market, Germany, Revenue ($m), USD Constant, Forecast, 2016-2023 74

Figure 35: Metered Dose Inhaler Devices Market, Germany, Volume (Units), Historic, 2009-2016 75

Figure 36: Metered Dose Inhaler Devices Market, Germany, Volume (Units), Forecast, 2016-2023 76

Figure 37: Metered Dose Inhaler Devices Market, Germany, Company Share (%) 2016 78

Figure 38: Needle Free Injections Market, Germany, Revenue ($m), USD Constant, Historic, 2009-2016 80

Figure 39: Needle Free Injections Market, Germany, Revenue ($m), USD Constant, Forecast, 2016-2023 81

Figure 40: Needle Free Injections Market, Germany, Volume (Units), Historic, 2009-2016 82

Figure 41: Needle Free Injections Market, Germany, Volume (Units), Forecast, 2016-2023 83

Figure 42: Needle Free Injections Market, Germany, Company Share (%) 2016 85

1.1 List of Tables

Table 1: Drug Delivery Devices Market, Germany, Revenue ($m), USD Constant, 2009-2023 14

Table 2: Drug Delivery Devices Market, Germany, Category Contribution by Revenue ($m), 2016 16

Table 3: Drug Delivery Devices Market, Germany, Category Comparison by Revenue ($m), 2009-2023 17

Table 4: Drug Delivery Devices Market, Germany, Revenue ($m), USD Constant, Historic, 2009-2016 19

Table 5: Drug Delivery Devices Market, Germany, Revenue ($m), USD Constant, Forecast, 2016-2023 21

Table 6: Drug Delivery Devices Market, Germany, Volume (Units), 2009-2023 23

Table 7: Drug Delivery Devices Market, Germany, Volume (Units), Historic, 2009-2016 25

Table 8: Drug Delivery Devices Market, Germany, Volume (Units), Forecast, 2016-2023 27

Table 9: Drug Delivery Devices Market, Germany, Company Share by Revenue ($m), USD Constant, 2016 29

Table 10: Central Venous Catheters Market, Germany, Segment Contribution (%), 2016 31

Table 11: Central Venous Catheters Market, Germany, Revenue ($m), USD Constant, Historic, 2009-2016 33

Table 12: Central Venous Catheters Market, Germany, Revenue ($m), USD Constant, Forecast, 2016-2023 35

Table 13: Central Venous Catheters Market, Germany, Volume (Units), Historic, 2009-2016 37

Table 14: Central Venous Catheters Market, Germany, Volume (Units), Forecast, 2016-2023 39

Table 15: Central Venous Catheters Market, Germany, Distribution Share by Revenue ($m), USD Constant, 2015-2016 40

Table 16: Central Venous Catheters Market, Germany, Company Share by Revenue ($m), USD Constant, 2016 42

Table 17: Infusion Systems Market, Germany, Segment Contribution (%), 2016 45

Table 18: Infusion Systems Market, Germany, Revenue ($m), USD Constant, Historic, 2009-2016 47

Table 19: Infusion Systems Market, Germany, Revenue ($m), USD Constant, Forecast, 2016-2023 49

Table 20: Ambulatory Infusion Pumps Market, Germany, Revenue ($m), USD Constant, Historic, 2009-2016 51

Table 21: Syringe Pumps Market, Germany, Revenue ($m), USD Constant, Historic, 2009-2016 53

Table 22: Ambulatory Infusion Pumps Market, Germany, Revenue ($m), USD Constant, Forecast, 2016-2023 55

Table 23: Syringe Pumps Market, Germany, Revenue ($m), USD Constant, Forecast, 2016-2023 57

Table 24: Infusion Systems Market, Germany, Volume (Units), Historic, 2009-2016 59

Table 25: Infusion Systems Market, Germany, Volume (Units), Forecast, 2016-2023 61

Table 26: Ambulatory Infusion Pumps Market, Germany, Volume (Units), Historic, 2009-2016 63

Table 27: Syringe Pumps Market, Germany, Volume (Units), Historic, 2009-2016 65

Table 28: Ambulatory Infusion Pumps Market, Germany, Volume (Units), Forecast, 2016-2023 67

Table 29: Syringe Pumps Market, Germany, Volume (Units), Forecast, 2016-2023 69

Table 30: Infusion Systems Market, Germany, Distribution Share by Revenue ($m), USD Constant, 2015-2016 70

Table 31: Infusion Systems Market, Germany, Company Share by Revenue ($m), USD Constant, 2016 72

Table 32: Metered Dose Inhaler Devices Market, Germany, Revenue ($m), USD Constant, Historic, 2009-2016 73

Table 33: Metered Dose Inhaler Devices Market, Germany, Revenue ($m), USD Constant, Forecast, 2016-2023 74

Table 34: Metered Dose Inhaler Devices Market, Germany, Volume (Units), Historic, 2009-2016 75

Table 35: Metered Dose Inhaler Devices Market, Germany, Volume (Units), Forecast, 2016-2023 76

Table 36: Metered Dose Inhaler Devices Market, Germany, Distribution Share by Revenue ($m), USD Constant, 2015-2016 77

Table 37: Metered Dose Inhaler Devices Market, Germany, Company Share by Revenue ($m), USD Constant, 2016 79

Table 38: Needle Free Injections Market, Germany, Revenue ($m), USD Constant, Historic, 2009-2016 80

Table 39: Needle Free Injections Market, Germany, Revenue ($m), USD Constant, Forecast, 2016-2023 81

Table 40: Needle Free Injections Market, Germany, Volume (Units), Historic, 2009-2016 82

Table 41: Needle Free Injections Market, Germany, Volume (Units), Forecast, 2016-2023 83

Table 42: Needle Free Injections Market, Germany, Distribution Share by Revenue ($m), USD Constant, 2015-2016 84

Table 43: Needle Free Injections Market, Germany, Company Share by Revenue ($m), USD Constant, 2016 86

Table 44: Drug Delivery Devices Market Pipeline Products 92

Table 45: Dietmar Hopp May Sell its Stake in LTS Lohmann Therapie-Systeme 98

Table 46: Luye Pharma Acquires Acino and Acino Supply for USD269 Million 99

Table 47: ICU Medical Acquires Hospira Infusion Systems Business from Pfizer 101

Table 48: Fresenius Raises USD742.5 Million in Private Placement of 0.875% Notes Due 2022 103

Table 49: Fresenius Raises USD742.5 Million in Private Placement of 1.5% Notes Due 2024 104

Table 50: Fresenius Raises USD742.5 Million in Private Placement of 2.125% Notes Due 2027 105

Table 51: Fresenius Raises USD530.4 Million in Private Placement of 3% Notes Due 2032 106

Table 52: Magforce Raises USD5.6 Million in Private Placement of Shares 107

Table 53: Alimera Sciences Enters into Licensing Agreement with pSivida 108

Table 54: Vetter Pharma International and Microdermics Enter into Agreement 109

Table 55: Ferring International and Alrise Biosystems Enter into Co-Development Agreement 110

Table 56: Bluegrass Vascular Enters into Partnership with Merit Medical 111

Table 57: Aequus Pharma to Enter into Licensing Agreement with Transdermal Research Pharm Labs 112

Table 58: Valeant Pharma Enters into Licensing Agreement with EyeGate Pharma 113

Table 59: Propeller Health Enters into Agreement with Novartis Pharma 115

Table 60: Neuronex Enters Into Licensing Agreement With SK Biopharmaceuticals For DZNS Technology 116

Table 61: Pfizer Terminates its Licensing Agreement with pSivida 117

Table 62: BioMed X Enters into Agreement with Merck 118

Table 63: Bayer Enters into Licensing Agreement with DelSiTech 119

Table 64: BioCorRx Enters into Licensing Agreement with Therakine 120

Table 65: AMW Raises USD6.4 Million in Venture Financing 121

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to sales [@] kenresearch.com
 

B. Braun Melsungen AG

Teleflex Inc

GlaxoSmithKline Plc

C. R. Bard Inc

Edwards Lifesciences Corp

AstraZeneca Plc

Boehringer Ingelheim GmbH

Pfizer Inc

Baxter International Inc

Merck & Co Inc

Becton Dickinson and Co

Fresenius Kabi AG

Smiths Medical

Medtronic Plc

Nipro Corp

Hospira Inc

Terumo Corp

Drug Delivery Devices, Central Venous Catheters, Needle Free Injections, Infusion Systems, Metered Dose Inhaler Devices, Value (USD), Volume (units), Revenues, Historic Revenues, Forecast Revenues, Average Price, Company Share, Distribution Share by Revenue, Company Share by Revenue, Pipeline Products, News, Deals, Key Companies, GlaxoSmithKline Plc, AstraZeneca Plc, Boehringer Ingelheim GmbH, Pfizer Inc, Merck & Co Inc, Sunovion Pharmaceuticals Inc, Teva Pharmaceutical Industries Ltd, INJEX-Equidyne Systems, Bioject Medical Technologies Inc , Antares Pharma Inc, PharmaJet Inc, MK Global Co., The European Pharma Group, Hospira Inc, Becton Dickinson and Co, Baxter International Inc, Fresenius Kabi AG, Medtronic plc, B. Braun Melsungen AG, Terumo Corp, Smiths Medical, Nipro Corp, JMS Co Ltd

select a license

Single User License
USD 5995 INR 404363
Site License
USD 11990 INR 808726
Corporate User License
USD 17985 INR 1213088

NEWSLETTER BY CATEGORY




Testimonials

An excellent provider. Thorough, precise and outstanding insight. They drill down to what we need and their reports are effective at integrating text with supporting graphics and charts. Their reports are a great resource to go back too. ...

Coherent, high-quality, thoroughly-researched reports. We received a very quick response to all our queries which eventually expedited the entire process....

Well structured, the insights they shared with us were very helpful and reliable. Their timely assistance make their services invaluable to us. I would highly recommend them and would definitely use them again in the future if needed...

The report sent to us was on the point, and its information was quite extensive, well structured, and well researched. More importantly what we valued was your response time and professionalism. As a leading global consulting firm, our clients expect high quality deliverables in short periods of time, so a reliable research partner is essential. For the price that you have charged the quality of your services were exceptional. We look forward to continue our relationship with your team on future engagements....

This is with regards to your report on India PVC pipes and fitting market outlook industry outlook to 2019. This is a very well written report and accept my compliments on the same.... ...



Related Products in vertical
Ken Research Pvt. Ltd. Unit 14, Tower B3, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India

download

Company Brochure

Engage with Us

sales [@] kenresearch.com